85 related articles for article (PubMed ID: 1692572)
21. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation.
Lenard J; Rabson A; Vanderoef R
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):158-62. PubMed ID: 7678335
[TBL] [Abstract][Full Text] [Related]
22. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.
Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S
Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749
[TBL] [Abstract][Full Text] [Related]
23. Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro.
McClure MO; Moore JP; Blanc DF; Scotting P; Cook GM; Keynes RJ; Weber JN; Davies D; Weiss RA
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):19-26. PubMed ID: 1346567
[TBL] [Abstract][Full Text] [Related]
24. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
25. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of anti-V3 domain antibody binding to human immunodeficiency virus type-1-infected cells by sulfated polysaccharides.
Okada T; Patterson BK; Gurney ME
Biochem Biophys Res Commun; 1995 Apr; 209(3):850-8. PubMed ID: 7537501
[TBL] [Abstract][Full Text] [Related]
27. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
Lederman S; Gulick R; Chess L
J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
[TBL] [Abstract][Full Text] [Related]
28. The proteinase inhibitor pepstatin A inhibits formation of reverse transcriptase in H9 cells infected with human immunodeficiency virus 1.
Grinde B; Hungnes O; Tjøtta E
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):269-74. PubMed ID: 2471542
[TBL] [Abstract][Full Text] [Related]
29. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin.
Okada T; Gurney ME
AIDS Res Hum Retroviruses; 1995 May; 11(5):571-5. PubMed ID: 7576913
[TBL] [Abstract][Full Text] [Related]
30. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
[TBL] [Abstract][Full Text] [Related]
31. Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities.
Chiba H; Inokoshi J; Okamoto M; Asanuma S; Matsuzaki Ki ; Iwama M; Mizumoto K; Tanaka H; Oheda M; Fujita K; Nakashima H; Shinose M; Takahashi Y; Omura S
Biochem Biophys Res Commun; 2001 Mar; 282(2):595-601. PubMed ID: 11401502
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue.
Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
Nucleic Acids Res; 1994 Dec; 22(25):5621-7. PubMed ID: 7530843
[TBL] [Abstract][Full Text] [Related]
33. Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
Mohan P; Schols D; Baba M; De Clercq E
Antiviral Res; 1992 Jun; 18(2):139-50. PubMed ID: 1384428
[TBL] [Abstract][Full Text] [Related]
34. Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus.
Bagasra O; Lischner HW
J Infect Dis; 1988 Nov; 158(5):1084-7. PubMed ID: 2460566
[No Abstract] [Full Text] [Related]
35. Anti-HIV-1 activity of enfuvirtide (T-20) by inhibition of bystander cell death.
Barretina J; Blanco J; Armand-Ugón M; Gutiérrez A; Clotet B; Esté JA
Antivir Ther; 2003 Apr; 8(2):155-61. PubMed ID: 12741628
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds.
Cushman M; Kanamathareddy S; De Clercq E; Schols D; Goldman ME; Bowen JA
J Med Chem; 1991 Jan; 34(1):337-42. PubMed ID: 1704066
[TBL] [Abstract][Full Text] [Related]
37. FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes.
Ono M; Wada Y; Wu Y; Nemori R; Jinbo Y; Wang H; Lo KM; Yamaguchi N; Brunkhorst B; Otomo H; Wesolowski J; Way JC; Itoh I; Gillies S; Chen LB
Nat Biotechnol; 1997 Apr; 15(4):343-8. PubMed ID: 9094135
[TBL] [Abstract][Full Text] [Related]
38. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines.
Patel M; Yanagishita M; Roderiquez G; Bou-Habib DC; Oravecz T; Hascall VC; Norcross MA
AIDS Res Hum Retroviruses; 1993 Feb; 9(2):167-74. PubMed ID: 8096145
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells.
Martin SJ; Matear PM; Vyakarnam A
J Immunol; 1994 Jan; 152(1):330-42. PubMed ID: 7902858
[TBL] [Abstract][Full Text] [Related]
40. A Fe(3+)/DNA complex induces an anti-human immunodeficiency virus factor(s) in CD4+ lymphocyte cell lines.
Nossik D; Kaplina E; Nossik N; Kalnina L; Tsutsumi R; Miura Y; Sera K; Itoh C; Sato S; Lvov D
Acta Virol; 1999 Feb; 43(1):25-30. PubMed ID: 10672340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
